학술논문
대한갑상선학회 갑상선분화암 진료권고안; 개요 및 요약 2024
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Overview and Summary 2024
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Overview and Summary 2024
Document Type
Article
Author
박영주 / Young Joo Park; 이은경 / Eun Kyung Lee; 송영신 / Young Shin Song; 구본석 / Bon Seok Koo; 권형주 / Hyungju Kwon; 김근영 / Keunyoung Kim; 김미진 / Mijin Kim; 김보현 / Bo Hyun Kim; 김원구 / Won Gu Kim; 김원배 / Won Bae Kim; 김원웅 / Won Woong Kim; 김정한 / Jung-han Kim; 김희경 / Hee Kyung Kim; 나희영 / Hee Young Na; 문신제 / Shin Je Moon; 문정은 / Jung-eun Moon; 박소현 / Sohyun Park; 박준욱 / Jun-ook Park; 방지인 / Ji-in Bang; 백교림 / Kyorim Back; 서영덕 / Youngduk Seo; 신동엽 / Dong Yeob Shin; 신수진 / Su-jin Shin; 안화영 / Hwa Young Ahn; 오소원 / So Won Oh; 우승훈 / Seung Hoon Woo; 원호륜 / Ho-ryun Won; 유창환 / Chang Hwan Ryu; 윤지희 / Jee Hee Yoon; 이가희 / Ka Hee Yi; 이민경 / Min Kyoung Lee; 이상우 / Sang-woo Lee; 이승은 / Seung Eun Lee; 이시훈 / Sihoon Lee; 이영아 / Young Ah Lee; 이준협 / Joon-hyop Lee; 이지예 / Ji Ye Lee; 이지은 / Jieun Lee; 이초록 / Cho Rok Lee; 임동준 / Dong-jun Lim; 임재열 / Jae-yol Lim; 전윤경 / Yun Kyung Jeon; 정경연 / Kyong Yeun Jung; 정아리 / Ari Chong; 정윤재 / Yun Jae Chung; 정찬권 / Chan Kwon Jung; 조관훈 / Kwanhoon Jo; 조윤영 / Yoon Young Cho; 홍아람 / A Ram Hong; 홍채문 / Chae Moon Hong; 강호철 / Ho-cheol Kang; 김선욱 / Sun Wook Kim; 정웅윤 / Woong Youn Chung; 박도준 / Do Joon Park; 나동규 / Dong Gyu Na
Source
International Journal of Thyroidology. May 31, 2024 17(1):1
Subject
Language
Korean
English
English
ISSN
2384-3799
Abstract
Differentiated thyroid cancer demonstrates a wide range of clinical presentations, from very indolent cases to those with an aggressive prognosis. Therefore, diagnosing and treating each cancer appropriately based on its risk status is important. The Korean Thyroid Association (KTA) has provided and amended the clinical guidelines for thyroid cancer management since 2007. The main changes in this revised 2024 guideline include 1) individualization of surgical extent according to pathological tests and clinical findings, 2) application of active surveillance in low-risk papillary thyroid microcarcinoma, 3) indications for minimally invasive surgery, 4) adoption of World Health Organization pathological diagnostic criteria and definition of terminology in Korean, 5) update on literature evidence of recurrence risk for initial risk stratification, 6) addition of the role of molecular testing, 7) addition of definition of initial risk stratification and targeting thyroid stimulating hormone (TSH) concentrations according to ongoing risk stratification (ORS), 8) addition of treatment of perioperative hypoparathyroidism, 9) update on systemic chemotherapy, and 10) addition of treatment for pediatric patients with thyroid cancer.